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Abstract
Background: Reliable prediction of antibody, or B-cell, epitopes remains challenging yet highly
desirable for the design of vaccines and immunodiagnostics. A correlation between antigenicity,
solvent accessibility, and flexibility in proteins was demonstrated. Subsequently, Thornton and
colleagues proposed a method for identifying continuous epitopes in the protein regions protruding
from the protein's globular surface. The aim of this work was to implement that method as a web-
tool and evaluate its performance on discontinuous epitopes known from the structures of
antibody-protein complexes.
Results: Here we present ElliPro, a web-tool that implements Thornton's method and, together
with a residue clustering algorithm, the MODELLER program and the Jmol viewer, allows the
prediction and visualization of antibody epitopes in a given protein sequence or structure. ElliPro
has been tested on a benchmark dataset of discontinuous epitopes inferred from 3D structures of
antibody-protein complexes. In comparison with six other structure-based methods that can be
used for epitope prediction, ElliPro performed the best and gave an AUC value of 0.732, when the
most significant prediction was considered for each protein. Since the rank of the best prediction
was at most in the top three for more than 70% of proteins and never exceeded five, ElliPro is
considered a useful research tool for identifying antibody epitopes in protein antigens. ElliPro is
available at http://tools.immuneepitope.org/tools/ElliPro.
Conclusion: The results from ElliPro suggest that further research on antibody epitopes
considering more features that discriminate epitopes from non-epitopes may further improve
predictions. As ElliPro is based on the geometrical properties of protein structure and does not
require training, it might be more generally applied for predicting different types of protein-protein
interactions.
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An antibody epitope, aka B-cell epitope or antigenic deter-
minant, is a part of an antigen recognized by either a par-
ticular antibody molecule or a particular B-cell receptor of
the immune system [1]. For a protein antigen, an epitope
may be either a short peptide from the protein sequence,
called a continuous epitope, or a patch of atoms on the
protein surface, called a discontinuous epitope. While
continuous epitopes can be directly used for the design of
vaccines and immunodiagnostics, the objective of discon-
tinuous epitope prediction is to design a molecule that
can mimic the structure and immunogenic properties of
an epitope and replace it either in the process of antibody
production–in this case an epitope mimic can be consid-
ered as a prophylactic or therapeutic vaccine–or antibody
detection in medical diagnostics or experimental research
[2,3].
If continuous epitopes can be predicted using sequence-
dependent methods built on available collections of
immunogenic peptides (for review see [4]), discontinuous
epitopes–that are mostly the case when a whole protein,
pathogenic virus, or bacteria is recognized by the immune
system–are difficult to predict or identify from functional
assays without knowledge of a three-dimensional (3D)
structure of a protein [5,6]. The first attempts at epitope
prediction based on 3D protein structure began in 1984
when a correlation was established between crystallo-
graphic temperature factors and several known continu-
ous epitopes of tobacco mosaic virus protein, myoglobin
and lysozyme [7]. A correlation between antigenicity, sol-
vent accessibility, and flexibility of antigenic regions in
proteins was also found [8]. Thornton and colleagues [9]
proposed a method for identifying continuous epitopes in
the protein regions protruding from the protein's globular
surface. Regions with high protrusion index values were
shown to correspond to the experimentally determined
continuous epitopes in myoglobin, lysozyme and myo-
haemerythrin [9].
Here we present ElliPro (derived from Ellipsoid and Pro-
trusion), a web-tool that implements a modified version
of Thornton's method [9] and, together with a residue
clustering algorithm, the MODELLER program [10] and
the Jmol viewer, allows the prediction and visualization of
antibody epitopes in protein sequences and structures.
ElliPro has been tested on a benchmark dataset of
epitopes inferred from 3D structures of antibody-protein
complexes [11] and compared with six structure-based
methods, including the only two existing methods devel-
oped specifically for epitope prediction, CEP [12] and
DiscoTope [13]; two protein-protein docking methods,
DOT [14] and PatchDock [15]; and two structure-based
methods for protein-protein binding site prediction, PPI-
PRED [16] and ProMate [17]. ElliPro is available at http:/
/tools.immuneepitope.org/tools/ElliPro.
Implementation
The tool input
ElliPro is implemented as a web accessible application
and accepts two types of input data: protein sequence or
structure (Fig. 1, Step 1). In the first case, the user may
input either a protein SwissProt/UniProt ID or a sequence
in either FASTA format or single letter codes and select
threshold values for BLAST e-value and the number of
structural templates from PDB that will be used to model
a 3D structure of the submitted sequence (Fig. 1, Step 2a).
In the second case, the user may input either a four-char-
acter PDB ID or submit her own PDB file in PDB format
(Fig. 1, Step 2b). If the submitted structure consists of
more than one protein chain, ElliPro will ask the user to
select the chain(s) upon which to base the calculation.
The user can change threshold values on the parameters
used by ElliPro for epitope prediction, namely, the mini-
mum residue score (protrusion index), denoted here as S,
between 0.5 and 1.0 and the maximum distance, denoted
as R, in the range 4 – 8Å.
3D Structure Modeling
If a protein sequence is used as input, ElliPro searches for
the protein or its homologues in PDB [18], using a BLAST
search [19]. If a protein cannot be found in PDB that
matches the BLAST criteria, MODELLER [10] is run to pre-
dict the protein 3D structure. The user may change the
threshold values for BLAST e-value and a number of tem-
plates that MODELLER uses as an input (Fig. 1, Step 2a).
ElliPro Method
ElliPro implements three algorithms performing the fol-
lowing tasks: (i) approximation of the protein shape as an
ellipsoid [20]; (ii) calculation of the residue protrusion
index (PI) [9]; and (iii) clustering of neighboring residues
based on their PI values.
Thornton's method for continuous epitope prediction
was based on the two first algorithms and only considered
Cα atoms [9]. It approximated the protein surface as an
ellipsoid, which can vary in sizes to include different per-
centages of the protein atoms; for example, the 90% ellip-
soid includes 90% of the protein atoms. For each residue,
a protrusion index (PI) was defined as percentage of the
protein atoms enclosed in the ellipsoid at which the resi-
due first becomes lying outside the ellipsoid; for example,
all residues that are outside the 90% ellipsoid will have PI
= 9 (or 0.9 in ElliPro). In implementing the first two algo-
rithms, ElliPro differs from Thornton's method by consid-
ering each residue's center of mass rather than its Cα
atom.Page 2 of 8
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BMC Bioinformatics 2008, 9:514 http://www.biomedcentral.com/1471-2105/9/514The third algorithm for clustering residues defines a dis-
continuous epitope based on the threshold values for the
protrusion index S and the distance R between each resi-
due's centers of mass. All protein residues with a PI values
greater than S are considered when calculating discontin-
uous epitopes. Clustering separate residues into discon-
tinuous epitopes involves three steps that are recursively
repeated until distinct clusters with no overlapping resi-
dues are formed. First, primary clusters are formed from
single residues and their neighboring residues within the
distance R. Second, secondary clusters are formed from
primary clusters where at least three centers of mass are
within the distance R from each other. Third, tertiary clus-
ters are formed from secondary clusters which contain
common residues. These tertiary clusters of residues repre-
sent distinct discontinuous epitopes predicted in the pro-
tein. The score for each epitope is defined as a PI value
averaged over epitope residues.
3D visualization of Predicted Epitopes
An open-source molecular viewer Jmol [21] was used to
visualize linear and discontinuous epitopes on the protein
3D structure. An example of epitope visualization is
shown in Fig. 2.
Results and Discussion
For evaluation of ElliPro performance and comparison
with other methods we used a previously established
benchmark approach for discontinuous epitopes [11]. We
tested ElliPro on a dataset of 39 epitopes present in 39
protein structures where only one discontinuous epitope
was known based on 3D structures of two-chain antibody
fragments with one-chain protein antigens [11].
Depending on the threshold values for parameters R and
S, ElliPro predicted different number of epitopes in each
protein; for an R of 6Å and S of 0.5, the average number
Screen shot of ElliPro input pageFigure 1
Screen shot of ElliPro input page.Page 3 of 8
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BMC Bioinformatics 2008, 9:514 http://www.biomedcentral.com/1471-2105/9/514of predicted epitopes in each protein analyzed was 4, with
a variance from 2 to 8. For example, for Plasmodium vivax
ookinete surface protein Pvs25 [PDB: 1Z3G, chain A],
ElliPro predicted four epitopes with scores of 0.763,
0.701, 0.645, and 0.508, respectively (Fig. 2).
For each predicted epitope in each protein, we calculated
the correctly (TP) and incorrectly predicted epitope resi-
dues (FN) and non-epitope residues, which were defined
as all other protein residues (TN and FN). The statistical
significance of a prediction, that is, the difference between
observed and expected frequencies of an actual epitope/
non-epitope residue in the predicted epitope/non-
epitope, was determined using Fisher's exact test (right-
tailed). The prediction was considered significant if the P-
value was = 0.05. Then, for each prediction the following
parameters were calculated:
Sensitivity (recall or true positive rate (TPR)) = TP/(TP + FN)
– a proportion of correctly predicted epitope residues (TP)
with respect to the total number of epitope residues
(TP+FN).
Specificity (or 1 – false positive rate (FPR)) = 1 - FP/(TN +
FP) – a proportion of correctly predicted non-epitope res-
idues (TN) with respect to the total number of non-
epitope residues (TN+FP).
Positive predictive value (PPV) (precision) = TP/(TP + FP) –
a proportion of correctly predicted epitope residues (TP)
Screen shots of the ElliPro result page for Plasmodium vivax ookinete surface protein Pvs25 [PDB:1Z3G, chain A] and Jmol vis-ualization f the first of the four predicted epitopesFigure 2
Screen shots of the ElliPro result page for Plasmodium vivax ookinete surface protein Pvs25 [PDB:1Z3G, chain 
A] and Jmol visualization of the first of the four predicted epitopes. The epitope residues are in yellow, the rest of 
the protein is in violet, antibody chains are in green and brown.Page 4 of 8
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Table 1: Overall performance of ElliPro in comparison with other methods#.
ElliPro (radius 6Å) PPI-PRED PatchDock ClusPro (DOT)
Best 
prediction 
(score 0.5)
Average 
(score 0.5)
1st 
prediction 
(score 0.7)
ProMate 
(patch)
1st patch best patch 1st model best 
model of 
top 10
1st model best 
model of 
top 10
CEP 
(average)
DiscoTope 
(-7.7)
Overall statistics
sensitivity 0.601 0.165 0.093 0.091 0.153 0.331 0.300 0.425 0.258 0.453 0.310 0.416
1-
specificity
0.138 0.109 0.047 0.083 0.161 0.135 0.135 0.114 0.079 0.067 0.223 0.214
precision 0.291 0.119 0.158 0.101 0.083 0.188 0.175 0.262 0.235 0.390 0.110 0.155
accuracy 0.840 0.832 0.879 0.841 0.780 0.819 0.816 0.846 0.863 0.892 0.739 0.754
AUC 0.732 0.528 0.523 0.504 0.496 0.598 0.583 0.656 0.589 0.693 0.544 0.601
P-value 0.00E+00 1.37E-04 9.52E-06 2.74E-01 1.0E+00 7.8E-30 9.0E-23 0.0E+00 7.9E-34 0.0E+00 4.3E-06 4.1E-25
Statistics averaged over epitopes
sensitivity 0.58 ± 0.25 0.17 ± 0.10 0.10 ± 0.20 0.09 ± 0.17 0.15 ± 0.24 0.34 ± 0.32 0.29 ± 0.26 0.42 ± 0.29 0.25 ± 0.31 0.46 ± 0.28 0.34 ± 0.28 0.43 ± 0.31
1-
specificity
0.12 ± 0.10 0.11 ± 0.04 0.05 ± 0.03 0.08 ± 0.03 0.16 ± 0.07 0.14 ± 0.07 0.15 ± 0.06 0.13 ± 0.07 0.10 ± 0.07 0.08 ± 0.05 0.28 ± 0.20 0.22 ± 0.15
precision 0.44 ± 0.22 0.13 ± 0.06 0.16 ± 0.28 0.11 ± 0.20 0.10 ± 0.17 0.21 ± 0.24 0.19 ± 0.20 0.30 ± 0.25 0.25 ± 0.33 0.41 ± 0.29 0.11 ± 0.08 0.18 ± 0.12
accuracy 0.85 ± 0.08 0.82 ± 0.05 0.87 ± 0.05 0.83 ± 0.05 0.77 ± 0.07 0.81 ± 0.08 0.80 ± 0.08 0.83 ± 0.09 0.84 ± 0.09 0.88 ± 0.07 0.69 ± 0.17 0.74 ± 0.12
AUC 0.73 ± 0.11 0.53 ± 0.03 0.53 ± 0.10 0.51 ± 0.09 0.50 ± 0.13 0.60 ± 0.17 0.57 ± 0.14 0.64 ± 0.17 0.58 ± 0.17 0.69 ± 0.15 0.53 ± 0.08 0.60 ± 0.13
# – best prediction, patch, or model corresponds to the most significant (minimal P-value) of the predicted epitopes
BMC Bioinformatics 2008, 9:514 http://www.biomedcentral.com/1471-2105/9/514with respect to the total number of predicted epitope res-
idues (TP+FN).
Accuracy (ACC) = (TP + TN)/(TP + FN + FP + TN) – a pro-
portion of correctly predicted epitope and non-epitope
residues with respect to all residues.
Area under the ROC Curve (AUC) – area under a graph rep-
resenting a dependency of TPR against FPR; that is, sensi-
tivity against 1-specificity. The AUC gives the general
performance of the method and is "equivalent to the
probability that the classifier will rank a randomly chosen
positive instance higher than a randomly chosen negative
instance" [22].
For example, for the first predicted epitope in Plasmodium
vivax ookinete surface protein Pvs25 [PDB:1Z3G, chain A]
(Fig. 2), for an R of 6Å and S of 0.5, TP = 13, FP = 13, TN
= 156, FN = 4, P-value = 5.55E-10, giving a sensitivity of
0.76, a specificity of 0.92, an accuracy of 0.91, and an AUC
of 0.84. The results and detailed statistics of ElliPro per-
formance for each epitope and other threshold values for
R and S are provided in the supplementary materials [see
Additional file 1].
The statistics averaged over all epitopes and overall statis-
tics calculated from FP, FN, TP, and TN values summa-
rized for the whole pool of epitope and non-epitope
residues are presented in Table 1 and Fig. 3. The results for
the methods other than ElliPro have been obtained as
described in [11]. ElliPro performed best, by AUC values,
with the score S set at 0.7 and the distance R set at 6Å
when the prediction with the highest score was considered
for each protein and with the score S set at 0.5 and the dis-
tance R set at 6Å when the best by significance or average
prediction was taken into account. Results are described
using these thresholds (Table 1, Fig. 3); the results at other
threshold values are provided in the supplementary mate-
rials [see Additional file 1].
ElliPro's top predictions, that are those with the highest
scores, correlated poorly with the discontinuous epitopes
known from 3D structures of antibody-protein complexes
(Table 1, overall statistics, AUC = 0.523). DiscoTope and
the first models from the docking methods performed
better, giving AUC values above 0.6, whereas protein-pro-
tein binding site predicting methods, ProMate and PPI-
PRED, performed worse. However, when the first predic-
tions with the highest score were considered, ElliPro was
the best among all the methods based on specificity (1-
specificity = 0.047) and comparable with DiscoTope by
precision (PPV = 0.158) (Table 1, overall statistics).
In a next set of metrics, we compared the performance
between prediction methods when choosing the best hit
within the top 10 predictions of each method. This
approach takes into account that each antigen harbors
multiple distinct binding sites for different antibodies.
Therefore it is expected that the top predicted site is not
necessarily recognized by the specific antibody used in the
dataset. This comparison directly applies only to the dock-
ing methods DOT and PatchDock as well as ElliPro. For
DiscoTope, only one epitope is predicted, while for CEP
no ranking is available to identify the top 10 predictions.
The docking methods DOT and PatchDock have an intrin-
sic advantage in this comparison over ElliPro, because
they use structures of both protein antigen and antibody
from the same antibody-protein complex in order to pre-
dict binding sites. To our surprise, when the best signifi-
cant prediction was considered for each protein, ElliPro
nevertheless gave the highest AUC value of 0.732, the
highest sensitivity of 0.601 and the second highest preci-
sion value of 0.29 among all the compared methods
(Table 1; Fig. 3, red circle). The docking methods gave the
AUC values of 0.693 for DOT and 0.656 for PatchDock,
when also the best prediction of the top ten was consid-
ered (Table 1, overall statistics; Fig. 3). The average
number of predicted epitopes for the analyzed proteins
was four, with the rank of the best prediction at most fifth;
for more than a half of proteins the rank was first or sec-
ond, and the rank first, second, or third for more than
70% of all proteins [see Additional file 1].
ElliPro is based on simple concepts. First, regions protrud-
ing from the globular surface of the protein are more
available for interaction with an antibody [9] and second
those protrusions can be determined by treating the pro-
tein as a simple ellipsoid [20]. Obviously, this is not
always the case, especially for multi-domain or large sin-
gle-domain proteins. However, no correlation between
the protein size, which varied from 51 to 429 residues
with an average value of 171, or number of domains (8
proteins among the 39 analyzed contained more than one
domain) and ElliPro performance was found (data not
shown).
Conclusion
ElliPro is a web-based tool for the prediction of antibody
epitopes in protein antigens of a given sequence or struc-
ture. It implements a previously developed method that
represents the protein structure as an ellipsoid and calcu-
lates protrusion indexes for protein residues outside of the
ellipsoid. ElliPro was tested on a benchmark dataset of
discontinuous epitopes inferred from 3D structures of
antibody-protein complexes. In comparison with six
other structure-based methods that can be used for
epitope prediction, ElliPro performed the best (AUC value
of 0.732) when the most significant prediction was con-
sidered for each protein. Since the rank of the best predic-Page 6 of 8
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BMC Bioinformatics 2008, 9:514 http://www.biomedcentral.com/1471-2105/9/514tion was at most three in more than 70% of proteins and
never exceeded five, ElliPro is considered a potentially
useful research tool for identifying antibody epitopes in
protein antigens.
While ElliPro was tested on antibody-protein binding
sites, it might be interesting to test it on other protein-pro-
tein interactions since it implements a method that is
based on geometrical properties of protein structure and
does not require training.
Comparison with DiscoTope, which is based on training
and utilizes epitope features such as amino acid propensi-
ties, residue solvent accessibility, spatial distribution, and
inter-molecular contacts, suggests that further research on
antibody epitopes which considers more features that dis-
criminate epitopes from non-epitopes may improve the
prediction of antibody epitopes.
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